Paul E. Mann's Insider Trades & SAST Disclosures
Paul E. Mann's most recent trade in ASP Isotopes Inc was a trade of 978,466 Common Stock done . Disclosure was reported to the exchange on Sept. 6, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Paul E. Mann.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ASP Isotopes Inc | Paul E. Mann | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2024 | 978,466 | 6,824,093 | - | - | Common Stock | |
| ASP Isotopes Inc | Paul E. Mann | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 15 Jul 2024 | 39,984 | 5,845,627 | - | - | Common Stock | |
| ASP Isotopes Inc | Paul E. Mann | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 718,143 | 5,805,643 | - | 0 | Common Stock | |
| ASP Isotopes Inc | Paul E. Mann | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2022 | 1,000,000 | 5,087,500 | - | 0 | Common Stock | |
| ASP Isotopes Inc | Paul E. Mann | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2022 | 1,000,000 | 4,087,500 | - | 0 | Common Stock | |
| ASP Isotopes Inc | Paul E. Mann | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 4.00 per share. | 15 Nov 2022 | 37,500 | 3,087,500 | - | 4 | 150,000 | Common Stock |
| Abeona Therapeutics Inc | Paul E. Mann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Sep 2022 | 13,400 | 16,907 (0%) | 0% | 0 | Common Stock | |
| Abeona Therapeutics Inc | Paul E. Mann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 49,084 | 49,084 | - | - | Stock Option (right to buy) | |
| Abeona Therapeutics Inc | Paul E. Mann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 38,590 | 38,590 (0%) | 0% | 0 | Common Stock | |
| Abeona Therapeutics Inc | Paul E. Mann | Director | Sale of securities on an exchange or to another person at price $ 2.38 per share. | 19 Feb 2021 | 45,566 | 0 (0%) | 0% | 2.4 | 108,502 | Common Stock |
| Abeona Therapeutics Inc | Paul E. Mann | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2021 | 45,566 | 0 | - | - | Stock Option (Right to Buy) | |
| Abeona Therapeutics Inc | Paul E. Mann | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.28 per share. | 19 Feb 2021 | 45,566 | 45,566 (0%) | 0% | 1.3 | 58,324 | Common Stock |
| Abeona Therapeutics Inc | Paul E. Mann | Director | Sale of securities on an exchange or to another person at price $ 2.34 per share. | 17 Feb 2021 | 132,664 | 0 (0%) | 0% | 2.3 | 310,168 | Common Stock |
| Abeona Therapeutics Inc | Paul E. Mann | Director | Sale of securities on an exchange or to another person at price $ 1.59 per share. | 18 Dec 2020 | 17,079 | 772,907 (0%) | 0% | 1.6 | 27,099 | Common Stock |
| Abeona Therapeutics Inc | Paul E. Mann | Director | Sale of securities on an exchange or to another person at price $ 1.49 per share. | 02 Dec 2020 | 30,488 | 789,986 (0%) | 0% | 1.5 | 45,369 | Common Stock |
| Abeona Therapeutics Inc | Paul E. Mann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2020 | 45,566 | 45,566 | - | - | Stock Option (right to buy) | |
| Abeona Therapeutics Inc | Paul E. Mann | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Nov 2020 | 45,566 | 0 | - | - | Stock Option (right to buy) | |
| Abeona Therapeutics Inc | Paul E. Mann | Director | Sale of securities on an exchange or to another person at price $ 1.04 per share. | 02 Nov 2020 | 30,488 | 820,474 (0%) | 0% | 1.0 | 31,589 | Common Stock |
| Abeona Therapeutics Inc | Paul E. Mann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Oct 2020 | 813,008 | 850,962 (1%) | 0% | 0 | Common Stock | |
| Abeona Therapeutics Inc | Paul E. Mann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2020 | 45,566 | 45,566 | - | - | Stock Option (right to buy) | |
| Abeona Therapeutics Inc | Paul E. Mann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2020 | 37,954 | 37,954 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges